These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25543261)

  • 21. MicroRNA-223 dose levels fine tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemia.
    Gentner B; Pochert N; Rouhi A; Boccalatte F; Plati T; Berg T; Sun SM; Mah SM; Mirkovic-Hösle M; Ruschmann J; Muranyi A; Leierseder S; Argiropoulos B; Starczynowski DT; Karsan A; Heuser M; Hogge D; Camargo FD; Engelhardt S; Döhner H; Buske C; Jongen-Lavrencic M; Naldini L; Humphries RK; Kuchenbauer F
    Exp Hematol; 2015 Oct; 43(10):858-868.e7. PubMed ID: 26163797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of microRNAs in normal and malignant hematopoiesis.
    Vasilatou D; Papageorgiou S; Pappa V; Papageorgiou E; Dervenoulas J
    Eur J Haematol; 2010 Jan; 84(1):1-16. PubMed ID: 19744129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-15a-5p and miR-21-5p contribute to chemoresistance in cytogenetically normal acute myeloid leukaemia by targeting PDCD4, ARL2 and BTG2.
    Vandewalle V; Essaghir A; Bollaert E; Lenglez S; Graux C; Schoemans H; Saussoy P; Michaux L; Valk PJM; Demoulin JB; Havelange V
    J Cell Mol Med; 2021 Jan; 25(1):575-585. PubMed ID: 33270982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA methyltransferase 1-mediated CpG methylation of the miR-150-5p promoter contributes to fibroblast growth factor receptor 1-driven leukemogenesis.
    Hu T; Chong Y; Cai B; Liu Y; Lu S; Cowell JK
    J Biol Chem; 2019 Nov; 294(48):18122-18130. PubMed ID: 31628193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circ-ANAPC7 is Upregulated in Acute Myeloid Leukemia and Appears to Target the MiR-181 Family.
    Chen H; Liu T; Liu J; Feng Y; Wang B; Wang J; Bai J; Zhao W; Shen Y; Wang X; Yang J; Ji Y; He A; Yang Y
    Cell Physiol Biochem; 2018; 47(5):1998-2007. PubMed ID: 29969755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptome analysis identifies key regulators and networks in Acute myeloid leukemia.
    Ye J; Luo D; Yu J; Zhu S
    Hematology; 2019 Dec; 24(1):487-491. PubMed ID: 31210592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-155 expression and function in AML: An evolving paradigm.
    Narayan N; Bracken CP; Ekert PG
    Exp Hematol; 2018 Jun; 62():1-6. PubMed ID: 29601851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-21 suppression impedes medulloblastoma cell migration.
    Grunder E; D'Ambrosio R; Fiaschetti G; Abela L; Arcaro A; Zuzak T; Ohgaki H; Lv SQ; Shalaby T; Grotzer M
    Eur J Cancer; 2011 Nov; 47(16):2479-90. PubMed ID: 21775132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas.
    Wang YQ; Guo RD; Guo RM; Sheng W; Yin LR
    J Cell Biochem; 2013 Jul; 114(7):1464-73. PubMed ID: 23296900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of miR-378 is frequent and may affect treatment outcomes in patients with acute myeloid leukemia.
    Qian J; Lin J; Qian W; Ma JC; Qian SX; Li Y; Yang J; Li JY; Wang CZ; Chai HY; Chen XX; Deng ZQ
    Leuk Res; 2013 Jul; 37(7):765-8. PubMed ID: 23582927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression Levels of Warburg-Effect Related microRNAs Correlate with each Other and that of Histone Deacetylase Enzymes in Adult Hematological Malignancies with Emphasis on Acute Myeloid Leukemia.
    Gaál Z; Oláh É; Rejtő L; Bálint BL; Csernoch L
    Pathol Oncol Res; 2017 Jan; 23(1):207-216. PubMed ID: 27864740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNAs expressed in hematopoietic stem/progenitor cells are deregulated in acute myeloid leukemias.
    Testa U; Pelosi E
    Leuk Lymphoma; 2015 May; 56(5):1466-74. PubMed ID: 25242094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of miR-21 and PDCD4 in patients with stage II esophageal carcinoma after surgical resection.
    Zhang J; Ma L; Shi D; Zhang Z; Yao C; Zhao X; Xu Q; Wen P; He L
    J Cell Biochem; 2018 Jun; 119(6):4783-4791. PubMed ID: 29331036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy?
    Falini B; Gionfriddo I; Cecchetti F; Ballanti S; Pettirossi V; Martelli MP
    Blood Rev; 2011 Nov; 25(6):247-54. PubMed ID: 21724308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-10a is aberrantly overexpressed in Nucleophosmin1 mutated acute myeloid leukaemia and its suppression induces cell death.
    Bryant A; Palma CA; Jayaswal V; Yang YW; Lutherborrow M; Ma DD
    Mol Cancer; 2012 Feb; 11():8. PubMed ID: 22348345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant expression of miR-9/9* in myeloid progenitors inhibits neutrophil differentiation by post-transcriptional regulation of ERG.
    Nowek K; Sun SM; Bullinger L; Bindels EM; Exalto C; Dijkstra MK; van Lom K; Döhner H; Erkeland SJ; Löwenberg B; Jongen-Lavrencic M
    Leukemia; 2016 Jan; 30(1):229-37. PubMed ID: 26174629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiological expression of miR-130a during differentiation of CD34
    Mammoli F; Parenti S; Lomiento M; Gemelli C; Atene CG; Grande A; Corradini R; Manicardi A; Fantini S; Zanocco-Marani T; Ferrari S
    Exp Cell Res; 2019 Sep; 382(1):111445. PubMed ID: 31152707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice.
    Basova P; Pospisil V; Savvulidi F; Burda P; Vargova K; Stanek L; Dluhosova M; Kuzmova E; Jonasova A; Steidl U; Laslo P; Stopka T
    Oncogene; 2014 Sep; 33(39):4735-45. PubMed ID: 24121269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two novel NPM1 mutations in an acute myeloid leukemia patient transformed from primary myelofibrosis.
    Park SH; Chi HS; Shim H; Jang S; Park CJ
    Int J Lab Hematol; 2013 Feb; 35(1):e1-3. PubMed ID: 22978565
    [No Abstract]   [Full Text] [Related]  

  • 40. Screening of prognostic risk microRNAs for acute myeloid leukemia.
    Gao HY; Wang W; Luo XG; Jiang YF; He X; Xu P; Chen X; Li XY
    Hematology; 2018 Dec; 23(10):747-755. PubMed ID: 29781401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.